Evidence map›Paper›PMID 39523803›Full record

ReviewESC heart failure2025

Interventional therapies for chronic heart failure: An overview of recent developments.

Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in ESC heart failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Gut microbiota's role in heart failure.Heart failure reviews · 2025
    Review
  3. Review
  4. LncRNA HOXA11-AS Promotes Myocardial Injury in Chronic Heart Failure by Sponging miR-342-3p.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bingchen GuoDepartment of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Si ShiDepartment of Respirology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Yutong GuoDepartment of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Jie XiongDepartment of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Bo WangDepartment of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Zengxiang DongDepartment of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Dianyu GaoDepartment of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.
Yingfeng TuDepartment of Cardiology, The First Affiliated Hospital of Harbin Medical University, Harbin, 150000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the prognosis of patients with HF. These advancements include transcatheter aortic valve replacement for severe aortic stenosis, transcatheter mitral valve repair for chronic mitral regurgitation, neuromodulation therapy for multiple targets and measures in the treatment of chronic HF and left ventricular assist device implantation for advanced HF (Figure 1). In this review, we aimed to provide an overview of the current progress in interventional therapies for chronic HF.

Indexed as

Heart-Assist DevicesHeart FailureChronic DiseaseHumansTranscatheter Aortic Valve ReplacementCardiac contractility modulationHeart failureInterventional therapyNeuromodulation therapy

Identifiers

PMID39523803
PMCPMC11911643

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.